The compounded GLP-1 market emerged partly due to supply limitations of branded products and partly due to prohibitive costs that left many patients unable to access treatment
Rong X, Kou Y, Zhang Y, Yang P, Tang R, Liu H
doi: 10.1016/S2468-1253(24)00188-2
Reviewed by Paul Holmes Paul Holmes Director of Science and Innovation at Naturecan Testing for large pharmaceutical & tobacco companies, Paul has built a wealth of scientific and regulatory knowledge, working on regulatory submissions to bodies such as the FDA and the MHRA
(2003) suggested that the cleft may enable large peptide substrates to access the active site, whereas the narrower tunnel formed by the -propeller could serve as a conduit for exit of dipeptide cleavage products
Maybe it's a fluctuation in glucose or it could be something more serious." Norah S